SCHEMBL4599565

SCHEMBL4599565

O=C(Oc1cccc(F)c1)N1CCOCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.68
HSD17B10 Q99714 1/20 0.68
SMN1; SMN2 Q16637 3/20 0.62
TSHR P16473 1/20 0.62
KMT2A Q03164 4/20 0.62
RAB9A P51151 2/20 0.62
MEN1 O00255 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
FAAH O00519 1/20 0.59
KDM4E B2RXH2 1/20 0.57
NPC1 O15118 1/20 0.57
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
ADORA2A P29274 1/20 0.55
ADORA1 P30542 1/20 0.55
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28324288 0.86 TSHR (0.59) SMN1; SMN2TSHRKMT2ARAB9AMEN1
SCHEMBL28372646 0.82 EPHX1 (0.68) EPHX1HSD17B10SMN1; SMN2TSHRKMT2A
SCHEMBL4598628 0.82 EPHX1 (0.68) EPHX1HSD17B10SMN1; SMN2TSHRKMT2A
SCHEMBL4599459 0.82 EPHX1 (0.68) EPHX1HSD17B10SMN1; SMN2TSHRKMT2A
SCHEMBL30595877 0.82 USP2 (0.49) EPHX1HSD17B10SMN1; SMN2TSHRFAAH
SCHEMBL21650810 0.82 FAAH (0.59) SMN1; SMN2FAAHCYP1A2CYP2C9CYP2C19
SCHEMBL30595861 0.82 USP2 (0.49) EPHX1HSD17B10SMN1; SMN2TSHRFAAH
SCHEMBL4197062 0.81 EPHX1 (1.00) EPHX1HSD17B10SMN1; SMN2TSHRKMT2A
SCHEMBL5101418 0.81 KMT2A (0.82) EPHX1HSD17B10SMN1; SMN2TSHRKMT2A
SCHEMBL28671891 0.79 FAAH (0.50) EPHX1HSD17B10SMN1; SMN2KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed